此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Effects of Exercise Intensity in Obese Children and Adolescents

A Multi-centre Randomized Controlled Trial Examining the Effects of High Intensity Interval Training on Cardio-metabolic Outcomes in Obese Children and Adolescents

The prevalence of paediatric obesity has increased over the last two decades and with it, an increased diagnosis of lifestyle-related diseases in children and adolescents. High intensity interval training has recently been explored as an alternate to traditional aerobic exercise in adults with chronic disease and has potential to induce rapid reversal of subclinical disease markers in obese children and adolescents.

High intensity interval training has recently been explored as an alternate to traditional aerobic exercise in adults with chronic disease and has potential to induce rapid reversal of subclinical disease markers in obese children and adolescents.

Goal: The primary aim of this randomised controlled trial is to evaluate the effectiveness of a high intensity interval training intervention on myocardial function, vascular function and visceral adipose tissue in obese children and adolescents at baseline, three and twelve months.

Method: Multi-centre randomised controlled trial of 100 obese children and adolescents in the cities of Trondheim (Norway) and Brisbane (Australia). Participants will be randomised to (1) high intensity interval training, (2) moderate intensity continuous training or (3) nutrition advise. Participants will partake in supervised exercise training and/or nutrition consultations for 3 months. Measurements for all study endpoints will occur at baseline, 3 months (post intervention) and 12 months (follow up).

Scientific Significance : This randomised controlled trial will general substantial information regarding the effects of exercise intensity on paediatric obesity, specifically the cardio-metabolic health of this at-risk population. It is expected that communication of results will allow for more robust and realistic guidelines regarding exercise prescription in this population to be formed while outlining the benefits of high intensity interval training on subclinical markers of disease.

研究概览

详细说明

Worldwide, childhood overweight and obesity rates are approximately 10%, this high incidence attributed to a physically inactive lifestyle and inappropriate nutrition. Early cohort studies illustrated that fifty per cent of obese children became obese adults and consequently had an higher risk for metabolic syndrome than obese adults who were not obese as children. Both female and male overweight children and adolescents had a 30% increase in all cause mortality. The increases in risk of death were independent of adult body mass index.

Systematic reviews suggest that lifestyle and exercise interventions in obese children and adolescents can lead to improvements in anthropometric and cardio-metabolic outcomes, but these are not inclusive of several important outcomes such as myocardial and vascular function or visceral adipose tissue.

研究类型

介入性

注册 (实际的)

100

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Trondheim、挪威
        • St Olavs Hospital
      • Brisbane、澳大利亚
        • University of Queensland

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

7年 至 16年 (孩子)

接受健康志愿者

有资格学习的性别

全部

描述

Inclusion Criteria:

- Obese (BMI ≥ 95th percentile - age and sex specific criteria)

Exclusion Criteria:

  • Elevated blood pressure (≥ 95th percentile for systolic or diastolic values)
  • Congenital heart disease
  • Coronary artery disease
  • Family history of hypertropic obstructive cardiomyopathy
  • Any abnormality during rest or stress echocardiography which indicates it would be unsafe to participate
  • Self reported kidney failure
  • Any major organ transplant
  • Considerable pulmonary disease including severe or poorly controlled asthma
  • Smoking
  • Diabetes
  • Epilepsy or a history of seizures
  • Orthopaedic or neurological limitations to exercise
  • Diagnosed attention deficit hypersensitivity disorder
  • Steroid medications
  • Participation in another research study

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:预防
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
实验性的:High intensity interval training
10-minute warm up at 60-70% of maximal heart rate (HRmax). Then walking, running or cycling at 85-95% of maximal heart rate at intervals of 4 x 4 minutes, with 3 minute active breaks (50-70% of HRmax) between intervals. A 5-minute cool down period.
Twelve weeks of 2-3 supervised training sessions each week.
其他名称:
  • 高强度间歇训练
healthy food choices, portion sizes and regular mealtimes
实验性的:Moderate intensity continuous training
walking, running or cycling continuously at 60-70% HRmax for 44 minutes.
healthy food choices, portion sizes and regular mealtimes
Twelve weeks of 2-3 supervised training sessions each week.
其他名称:
  • 通信技术部
有源比较器:nutritional advice
10 individual nutrition consultations with an accredited dietitian over the 12 month period. Content of consultations will include healthy food choices, portion sizes and regular mealtimes.
healthy food choices, portion sizes and regular mealtimes
无干预:non-obese children
100 healthy non-obese children aged 7-16 (controls)

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Peak systolic tissue velocity
大体时间:12 weeks
systolic tissue Doppler velocity assessed during resting and stress echocardiography
12 weeks

次要结果测量

结果测量
措施说明
大体时间
Subcutaneous and total abdominal adipose tissue
大体时间:12 weeks, 12 months
Assessed using MRI
12 weeks, 12 months
Cardiorespiratory fitness (VO2peak)
大体时间:12 weeks, 12 months
Assessed using a maximal treadmill test
12 weeks, 12 months
Body composition
大体时间:12 weeks, 12 months
Assessed using DXA (UQ), BodPod (NTNU)
12 weeks, 12 months
Blood biochemistry
大体时间:12 weeks, 12 months
Analysed for lipids, glucose, insulin, inflammatory makers, satiety hormones, oxidative stress
12 weeks, 12 months
Physical activity
大体时间:12 weeks, 12 months
Assessed through 7 day accelerometry
12 weeks, 12 months
Dietary analysis
大体时间:12 weeks, 12 months
Assessed through a three-day food record
12 weeks, 12 months
Myocardial structure and cardiac adipose tissue (UQ)
大体时间:12 weeks
Assessed through cardiac MRI; participants > 12 years only
12 weeks
Arterial stiffness
大体时间:12 weeks, 12 months
Assessed through pulse wave velocity and pulse wave analysis
12 weeks, 12 months
Autonomic function
大体时间:12 weeks, 12 months
Assessed through heart rate variability and heart rate recovery
12 weeks, 12 months
Quality of life
大体时间:12 weeks, 12 months
Assessed through the Paediatric Quality of Life Inventory
12 weeks, 12 months
Visceral adipose tissue
大体时间:12 weeks, 12 months
assessed by magnetic resonance imaging (MRI)
12 weeks, 12 months
Vascular function
大体时间:12 weeks, 12 months
Assessed through flow mediated dilation procedure
12 weeks, 12 months
Peak systolic tissue velocity
大体时间:12 months
systolic tissue Doppler velocity assessed during resting and stress echocardiography
12 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2013年11月1日

初级完成 (实际的)

2017年3月31日

研究完成 (实际的)

2017年3月31日

研究注册日期

首次提交

2013年11月18日

首先提交符合 QC 标准的

2013年11月18日

首次发布 (估计)

2013年11月25日

研究记录更新

最后更新发布 (实际的)

2018年2月20日

上次提交的符合 QC 标准的更新

2018年2月19日

最后验证

2018年2月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

研究美国 FDA 监管的设备产品

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

3
订阅